Note: Ingredients listed on restricted chemical lists
EC/CAS
238-877-9/14807-96-6
Name of the chemical
Talc
Concentration
*
EC/CAS
231-545-4/7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
*
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
>=20%
General Information
Revision date
2025-11-01
Product name
Estramustine Phosphate Sodium Capsules
Product name
Estramustine Phosphate Sodium Capsules
Identification on the label/Trade name
EMCYT; ESTRACYT
Product Synonyms
Estradiol, 3-(bis(2-chloroethyl)carbamate)
Chemical name
Nitrogen Mustard
1.2.1 Relevant identified uses
Pharmaceutical product used as Antineoplastic
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H360Df
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
OSHA Classification of the substance or mixture
2.3 Other hazards
Not applicable (HNOC) An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8). Estramustine Phosphate Sodium Pfizer OEL TWA-8 Hr Sodium lauryl sulfate Pfizer OEL TWA-8 Hr PBT & vPvB 2 µg/m3 300 µg/m3 The product does not contain any substance(s) classified as PBT or vPvB. Endocrine Disruptor Information Contains a known or suspected endocrine disruptor. Chemical name Endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100(3) or Commission Regulation (EU) 2018/605(4) Estramustine Phosphate Sodium Substance has endocrine disrupting properties Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
Signal word
Danger
Hazard statements
H351 - Suspected of causing cancer H360Df - May damage the unborn child. Suspected of damaging fertility EUH380 - May cause endocrine disruption in humans EUH430 - May cause endocrine disruption in the environment
Precautionary statements
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P280 - Wear protective gloves/protective clothing/eye protection/face protection P308 + P313 - IF exposed or concerned: Get medical advice/attention P405 - Store locked up P501 - Dispose of contents/container in accordance with local, regional, national, and international regulations as applicable Unknown aquatic toxicity Contains 68 % of components with unknown hazards to the aquatic environment.
2.1 Classification of the substance or mixture
GHS - Classification: Regulated according to Regulation (EC) 1272/2008 and/or other applicable regulations. Carcinogenicity Category 2 - (H351) Reproductive toxicity Category 1B - (H360Df) Endocrine disruption for human health Category 1 - (EUH380) Endocrine disruption for the environment Category 1 - (EUH430) OSHA Classification Hazards not otherwise classified (HNOC) Not applicable Hazards classified under paragraph (d)(1)(ii) of 1910.1200 Not applicable